These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 7953294
1. Mezerein and 12-deoxyphorbol 13-isobutyrate, protein kinase C ligands with differential biological activities, do not distinguish PKC-isotypes alpha, beta 1, beta 2, and gamma. Driedger PE, Stabel S, Frith D, Horgan TJ. Recept Channels; 1994; 2(2):99-106. PubMed ID: 7953294 [Abstract] [Full Text] [Related]
2. Characterization of phorbol ester binding to protein kinase C isotypes. Dimitrijević SM, Ryves WJ, Parker PJ, Evans FJ. Mol Pharmacol; 1995 Aug; 48(2):259-67. PubMed ID: 7651359 [Abstract] [Full Text] [Related]
3. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity. Bögi K, Lorenzo PS, Szállási Z, Acs P, Wagner GS, Blumberg PM. Cancer Res; 1998 Apr 01; 58(7):1423-8. PubMed ID: 9537243 [Abstract] [Full Text] [Related]
4. The differential effects of protein kinase C activators and inhibitors on rat anterior pituitary hormone release. Thomson FJ, Johnson MS, Mitchell R, Wolbers WB, Ison AJ, MacEwan DJ. Mol Cell Endocrinol; 1993 Aug 01; 94(2):223-34. PubMed ID: 8224525 [Abstract] [Full Text] [Related]
5. Specific binding of [20-3H]12-deoxyphorbol 13-isobutyrate to phorbol ester receptor subclasses in mouse skin particulate preparations. Dunn JA, Blumberg PM. Cancer Res; 1983 Oct 01; 43(10):4632-7. PubMed ID: 6309373 [Abstract] [Full Text] [Related]
6. Relationship between mezerein-mediated biological responses and phorbol ester receptor occupancy. Jaken S, Shupnik MA, Blumberg PM, Tashjian AH. Cancer Res; 1983 Jan 01; 43(1):11-4. PubMed ID: 6600158 [Abstract] [Full Text] [Related]
7. Differential activation by daphnetoxin and mezerein of PKC-isotypes alpha, beta I, delta and zeta. Saraiva L, Fresco P, Pinto E, Portugal H, Gonçalves J. Planta Med; 2001 Dec 01; 67(9):787-90. PubMed ID: 11745011 [Abstract] [Full Text] [Related]
8. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Kazanietz MG, Areces LB, Bahador A, Mischak H, Goodnight J, Mushinski JF, Blumberg PM. Mol Pharmacol; 1993 Aug 01; 44(2):298-307. PubMed ID: 8355667 [Abstract] [Full Text] [Related]
9. Phorbol ester and diacylglycerol activation of native protein kinase C species from various tissues. Johnson MS, Simpson J, MacEwan DJ, Ison A, Clegg RA, Connor K, Mitchell R. Mol Cell Biochem; 1995 May 24; 146(2):127-37. PubMed ID: 7565642 [Abstract] [Full Text] [Related]
10. Activation of conventional mammalian protein kinase C isoforms expressed in budding yeast modulates the cell doubling time--a potential in vivo screen for protein kinase C activators. Shieh HL, Hansen H, Zhu J, Riedel H. Cancer Detect Prev; 1996 May 24; 20(6):576-89. PubMed ID: 8939343 [Abstract] [Full Text] [Related]
11. Activation of the PKC-isotypes alpha, beta 1, gamma, delta and epsilon by phorbol esters of different biological activities. Ryves WJ, Evans AT, Olivier AR, Parker PJ, Evans FJ. FEBS Lett; 1991 Aug 19; 288(1-2):5-9. PubMed ID: 1879564 [Abstract] [Full Text] [Related]
12. Activation of protein kinase C by non-phorbol tumor promoter, mezerein. Miyake R, Tanaka Y, Tsuda T, Kaibuchi K, Kikkawa U, Nishizuka Y. Biochem Biophys Res Commun; 1984 Jun 15; 121(2):649-56. PubMed ID: 6233978 [Abstract] [Full Text] [Related]
13. The structural requirements for phorbol esters to enhance noradrenaline and dopamine release from rat brain cortex. Kotsonis P, Majewski H. Br J Pharmacol; 1996 Sep 15; 119(1):115-25. PubMed ID: 8872364 [Abstract] [Full Text] [Related]
14. Differential activation and inhibition of lymphocyte proliferation by phorbol esters, mezerein, teleocidin, and okadaic acid. Grove DS, Mastro AM. Cancer Res; 1991 Jan 01; 51(1):82-8. PubMed ID: 1988110 [Abstract] [Full Text] [Related]
15. Protein kinase C isoenzymes display differential affinity for phorbol esters. Analysis of phorbol ester receptors in B cell differentiation. Marquez C, Martinez C, Kroemer G, Bosca L. J Immunol; 1992 Oct 15; 149(8):2560-8. PubMed ID: 1401894 [Abstract] [Full Text] [Related]
16. Differential irreversible insertion of protein kinase C into phospholipid vesicles by phorbol esters and related activators. Kazanietz MG, Krausz KW, Blumberg PM. J Biol Chem; 1992 Oct 15; 267(29):20878-86. PubMed ID: 1400402 [Abstract] [Full Text] [Related]
17. Second stage tumor promoters: differences in biological potency and phorbol ester receptor affinity in C6 cells. Leach KL, Frost MM, Blumberg PM, Bressler JP. Cancer Lett; 1987 Aug 15; 36(2):139-47. PubMed ID: 3040225 [Abstract] [Full Text] [Related]
18. Evidence that protein kinase C alpha has reduced affinity towards 1,2-dioctanoyl-sn-glycerol: the effects of lipid activators on phorbol ester binding and kinase activity. MacEwan DJ, Mitchell R, Johnson MS, Thomson FJ, Lutz EM, Clegg RA, Connor K. Eur J Pharmacol; 1993 Jun 15; 246(1):9-18. PubMed ID: 8354345 [Abstract] [Full Text] [Related]
19. Conventional-type protein kinase C contributes to phorbol ester-induced inhibition of rat myometrial tension. Kim B, Kim YS, Ahn J, Kim J, Cho S, Won KJ, Ozaki H, Karaki H, Lee SM. Br J Pharmacol; 2003 May 15; 139(2):408-14. PubMed ID: 12770946 [Abstract] [Full Text] [Related]
20. Heterogeneity of [3H]phorbol 12,13-dibutyrate binding in primary mouse keratinocytes at different stages of maturation. Dunn JA, Jeng AY, Yuspa SH, Blumberg PM. Cancer Res; 1985 Nov 15; 45(11 Pt 1):5540-6. PubMed ID: 3863706 [Abstract] [Full Text] [Related] Page: [Next] [New Search]